GLP-1 medications, or glucagon-like peptide-1 receptor agonists, are a class of drugs primarily used to manage type 2 diabetes and, more recently, obesity
Both are self-administered under the skin via an injection pen
Watanabe S, Kawamoto S, Ohtani N, Hara E (2017) Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases
Many people dealing with long-lasting or chronic pain often report more than one type of pain
The Double Hit: Weight Loss + Direct Skin Aging The result is a double-aging effect part of it from losing structural fat (which happens with any major weight loss), but part of it from biological changes to the skin itself that appear to be caused by the medication
A Mercer study (2024) reported that 44% of U.S